Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Tenhunen

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Regulatory Peptides|April 20, 2005
Posttranscriptional activation of BNP gene expression in response to increased left ventricular wall stress: role of calcineurin and PKCOlli Tenhunen, István Szokodi, Heikki Ruskoaho
Duodecim; Laaketieteellinen Aikakauskirja|August 5, 2015
[Adverse cardiac effects associated with anticancer drugs]Jarkko Piuhola, Olli Tenhunen, Risto Kerkelä
Duodecim; Laaketieteellinen Aikakauskirja|December 16, 2017
New study designs in clinical drug developmentOlli Tenhunen, Miia Turpeinen, Pekka Kurki
Clinical Pharmacology and Therapeutics|June 25, 2020
Single-Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019Olli Tenhunen, Florian Lasch, Anja Schiel, et al.
Pflugers Archiv : European Journal of Physiology|January 26, 2002
Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathwaysNina Hautala, Olli Tenhunen, Istvan Szokodi, et al.
Journal of Cancer Research and Clinical Oncology|June 7, 2018
Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patientsTiina Moilanen, Anna Jokimäki, Olli Tenhunen, et al.
Clinical Pharmacology and Therapeutics|May 13, 2025
Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade-OffsFrancesco Pignatti, Filip Josephson, Pierre Demolis, et al.
Circulation Research|July 29, 2006
Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heartOlli Tenhunen, Jaana Rysä, Mika Ilves, et al.
Circulation. Heart Failure|March 5, 2010
GATA-4 is an angiogenic survival factor of the infarcted heartJaana Rysä, Olli Tenhunen, Raisa Serpi, et al.
The Journal of Biological Chemistry|March 31, 2004
Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heartOlli Tenhunen, Balázs Sármán, Risto Kerkelä, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Regulatory Peptides|April 20, 2005
Posttranscriptional activation of BNP gene expression in response to increased left ventricular wall stress: role of calcineurin and PKCOlli Tenhunen, István Szokodi, Heikki Ruskoaho
Duodecim; Laaketieteellinen Aikakauskirja|August 5, 2015
[Adverse cardiac effects associated with anticancer drugs]Jarkko Piuhola, Olli Tenhunen, Risto Kerkelä
Duodecim; Laaketieteellinen Aikakauskirja|December 16, 2017
New study designs in clinical drug developmentOlli Tenhunen, Miia Turpeinen, Pekka Kurki
Clinical Pharmacology and Therapeutics|June 25, 2020
Single-Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019Olli Tenhunen, Florian Lasch, Anja Schiel, et al.
Pflugers Archiv : European Journal of Physiology|January 26, 2002
Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathwaysNina Hautala, Olli Tenhunen, Istvan Szokodi, et al.
Journal of Cancer Research and Clinical Oncology|June 7, 2018
Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patientsTiina Moilanen, Anna Jokimäki, Olli Tenhunen, et al.
Clinical Pharmacology and Therapeutics|May 13, 2025
Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade-OffsFrancesco Pignatti, Filip Josephson, Pierre Demolis, et al.
Circulation Research|July 29, 2006
Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heartOlli Tenhunen, Jaana Rysä, Mika Ilves, et al.
Circulation. Heart Failure|March 5, 2010
GATA-4 is an angiogenic survival factor of the infarcted heartJaana Rysä, Olli Tenhunen, Raisa Serpi, et al.
The Journal of Biological Chemistry|March 31, 2004
Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heartOlli Tenhunen, Balázs Sármán, Risto Kerkelä, et al.
Pageof 3